Feb. 15. 2024
Osaka, Japan – February 15, 2024 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Motohiko Kimura) received approvals by the Ministry of Health, Labour and Welfare for three generic drugs with four strengths. The one compound marked with an asterisk below is approved for the first time as generics.
The list of approved products
1. Zonisamide OD Tablets TRE
| Generic name | Zonisamide |
|---|---|
| Strengths | OD Tablets: 25mg, 50mg |
| Brand products | TRERIEF® OD Tablets 25mg, 50mg |
2. Zinc Acetate Granules
| Generic name | Zinc Acetate Hydrate |
|---|---|
| Strengths | Granules: 5% |
| Brand products | NOBELZIN® Granules 5% |
3. Sugammadex Intravenous Injection Syringes
| Generic name | Sugammadex Sodium* |
|---|---|
| Strengths | Intravenous Injection Syringes: 200mg |
| Brand products | BRIDION® Intravenous 200mg |
The products announced in this press release are not approved by the Food & Drug Administration for sale and distribution in the United States.